Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized medicine in nonalcoholic fatty liver disease.

Clinical and molecular hepatology - 1 Oct 2022

Pirola Carlos J, Sookoian Silvia

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Lipase
Share to Liver
Share to Non-alcoholic Fatty Liver Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 35748062
DOI: 10.3350/cmh.2022.0175
PMCID: PMC9597218

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized medicine in nonalcoholic fatty liver disease.PMID 35748062Read ↗

Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs.Semantic proximity Read ↗

Recent advances in understanding and managing non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Present and future therapeutic strategies in non-alcoholic fatty liver disease.Semantic proximity Read ↗

The genetic epidemiology of nonalcoholic fatty liver disease: toward a personalized medicine.Semantic proximity Read ↗

The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver DiseaseSemantic proximity Read ↗

Epigenetics in NAFLD/NASH: Targets and therapySemantic proximity Read ↗

[Progress in the study of nonalcoholic fatty liver disease: insights from research in 2013].Semantic proximity Read ↗

Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatmentSemantic proximity Read ↗

Non-alcoholic Fatty Liver Disease (NAFLD) Management in the CommunitySemantic proximity Read ↗

Personalized medicine: Special treatment.Semantic proximity Read ↗

Personalized medicine in lipid-modifying therapy.Semantic proximity Read ↗

Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.